Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?

In Parkinson's disease (PD) depletion of dopamine in the nigro-striatal pathway is a main pathological hallmark that requires continuous and focal restoration. Current predominant treatment with intermittent oral administration of its precursor, Levodopa (l-dopa), remains the gold standard but pharm...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	C. Laloux, F. Gouel, C. Lachaud, K. Timmerman, B. Do Van, A. Jonneaux, M. Petrault, G. Garcon, N. Rouaix, C. Moreau, R. Bordet, J.A. Duce, J.C. Devedjian, D. Devos
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2017-07-01
סדרה:	Neurobiology of Disease
נושאים:	Parkinson's disease Dopamine l-dopa related motor complications Treatment–disease modifying effect
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S096999611730061X
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!